Life Sciences

State advisory board members received money from pharma companies

Pharma Compliance Alert, August 29, 2007

An Associated Press review of records in Minnesota founds that two members of the eight-member state advisory panel received large payments from pharmaceutical companies for speaking about their products.

The two members, a psychiatrist and a pharmacist, claim the money-including $350,000 to one of them-did not influence their work on the panel, which helps select which drugs are used in Medicaid programs.

State officials plan to review the panel's past actions for any bias tied to the payments. However, votes were not recorded in the meeting minutes, making it more difficult to track bias. Officials plan to require the committee to begin recording how each member votes and will screen appointees to two dozen committees for ties to drug companies.

Minnesota is one of only three states that require drug companies to report payments to doctors for lectures, consulting, research, and other services.

Click here for more on this story.

Most Popular

Related Articles